Pricing Log in Create free account
Friday 6 November 2026 Export RCUS’s income statement to Excel — free account

Arcus Biosciences, Inc.

RCUS Healthcare Biotechnology

Arcus Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $247.0 million, down 4.26% from fiscal 2024.

Revenue
−65.4%
EPS
+21.3%
Free cash flow
+9.28%
Total debt
+4.08%

Quarter to September 2026, against a year earlier

18.27 0.58 +3.28%
Market cap
$2.5B
P/E
0.0×
Fwd P/E
−5.1×
Dividend yield
—
F-score
0/9
Altman Z
1.11
Beneish M
−2.42
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Arcus Biosciences, Inc. (RCUS) Current ratio

Alert me on Current ratio

Arcus Biosciences, Inc.'s current ratio at the end of the quarter to 30 September 2026 was 3.3×, down 1.0× from fiscal 2025 (4.4×). Over the past ten years it has ranged from 4.4× (fiscal 2025) to 18.0× (fiscal 2016) — the current reading is the lowest in ten years. That is below the Biotechnology industry median of 4.9× and above the Healthcare sector median of 3.1×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 4.4× (3.03%)
FY2024 4.5× (0.46%)
FY2023 4.5× (18.31%)
FY2022 5.5× (27.28%)
FY2021 7.6× 25.71%
FY2020 6.0× (28.74%)
FY2019 8.5× (44.50%)
FY2018 15.3× 10.02%
FY2017 13.9× (22.68%)
FY2016 18.0× —

Quarterly newest first

Period Current ratio Change
Sep 2026 3.3× (12.61%)
Jun 2026 3.8× (5.45%)
Mar 2026 4.0× (7.36%)
Dec 2025 4.4× 19.54%
32 more quarters

Against its own ten years

Low 4.4× High 18.0×
Ten-year median 6.8×
Current reading's percentile 10

Current ratio against peers

Company Current ratio
MBX MBX Biosciences, Inc. compare 18.1×
BEAM Beam Therapeutics Inc. compare 13.0×
PHVS Pharvaris N.V. compare 11.9×
NAMS NewAmsterdam Pharma Company N.V. compare 11.8×
IDYA IDEAYA Biosciences, Inc. compare 9.0×
XNCR Xencor, Inc. compare 6.4×
RXRX Recursion Pharmaceuticals, Inc. compare 5.0×
RCUS Arcus Biosciences, Inc. 3.3×
ZLAB Zai Lab Limited Unsponsored ADR compare 2.0×
Biotechnology industry median 4.9×
Healthcare sector median 3.1×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on RCUS